Dear Friends:
DARPA (Defense Advanced Research Projects Agency) is the research agency of the U.S. military and they don't just look at weapons and other stuff like that!
Their scientists also explore a lot of civilian issues as well!
The way I see it anyway!
DARPA (Defense Advanced Research Projects Agency) is the research agency of the U.S. military and they don't just look at weapons and other stuff like that!
Their scientists also explore a lot of civilian issues as well!
The Pentagon’s cutting edge science department is working to create a therapeutic “shield” that could be mass-produced to provide temporary protection for people from diseases like the coronavirus, boosting their immunity until an actual vaccine is developed. The result could also help slow the viruses’ advance, buying time for hard-pressed hospitals and clinics worldwide.
The Defense Advanced Research Projects Agency, or DARPA, has funded efforts to create such therapies from studying COVID-19 samples from individuals who have already recovered from the virus. Scientists working with the organization’s Pandemic Prevention Platform (PPP) are sequencing the B cells of one individual who recovered from COVID-19. B cells create antibodies, proteins created by the human immune system to fight a particular invading microorganism.
If scientists can successfully sequence the B cells, the hope is that they can create a therapy that causes humans to build up an arsenal of COVID-19-fighting antibodies before infection takes place. That could make it more difficult for a person treated with the therapy to come down with the disease, buying time until that person can be vaccinated. According to DefenseOne, the therapy might also be useful for those already infected with the virus.Let's hope they make some headway since a readily available vaccine is about a year...... to a year and a half away!
The way I see it anyway!
No comments:
Post a Comment